Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chularat Hospital PCLBKK:CHG -0.66%81 Return-on-Tangible-Equity is 12.75% as of Mar. 2026, which is 32% below its 10-year median of 18.83. GuruFocus rates BKK:CHG with a GF Score™ of 81/100 and a GF Value™ of ฿2.60 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 576 Healthcare Providers & Services companies, Chularat Hospital PCL ranks better than 54.34% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Chularat Hospital PCL's annualized net income for the quarter that ended in Mar. 2026 was ฿991 Mil. Chularat Hospital PCL's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ฿7,767 Mil. Therefore, Chularat Hospital PCL's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 12.75%.
The historical rank and industry rank for Chularat Hospital PCL's Return-on-Tangible-Equity or its related term are showing as below:
BKK:CHG'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 12.24 Med: 18.83 Max: 73.57
Current: 12.45
During the past 13 years, Chularat Hospital PCL's highest Return-on-Tangible-Equity was 73.57%. The lowest was 12.24%. And the median was 18.83%.
BKK:CHG's Return-on-Tangible-Equity is ranked better than 54.34% of 576
companies
in the Healthcare Providers & Services industry
Industry Median: 10.17
vs BKK:CHG: 12.45
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Chularat Hospital PCL Return-on-Tangible-Equity Related Terms
Chularat Hospital PCL Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Chularat Hospital PCL's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:CHG vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Chularat Hospital PCL's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chularat Hospital PCL Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chularat Hospital PCL's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Chularat Hospital PCL's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 12.75% mean?
Chularat Hospital PCL (BKK:CHG) has a Return-on-Tangible-Equity of 12.75% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Chularat Hospital PCL and its competitors. This is 32% below median its historical median of 18.83. Over the past decade, Chularat Hospital PCL's Return-on-Tangible-Equity has ranged from 12.24 to 73.57. According to the industry distribution chart, Chularat Hospital PCL ranks #263 out of 576 companies in the Healthcare Providers & Services industry, placing it in the top 45.7%.
Is Chularat Hospital PCL's Return-on-Tangible-Equity too high?
Chularat Hospital PCL's current Return-on-Tangible-Equity of 12.75% is 32% below median its 10-year median of 18.83. Over the past 10 years, this metric has ranged from a low of 12.24 to a high of 73.57. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.17. Chularat Hospital PCL's value of 12.75% is 25.4% above this industry median. Based on the distribution chart, Chularat Hospital PCL ranks #263 out of 576 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Chularat Hospital PCL has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chularat Hospital PCL's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Chularat Hospital PCL ranks #263 out of 576 companies for Return-on-Tangible-Equity. This puts Chularat Hospital PCL in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.17. Chularat Hospital PCL's value of 12.75% is 25.4% above this benchmark. Historically, Chularat Hospital PCL's own Return-on-Tangible-Equity has ranged from 12.24 to 73.57 over the past decade. While the company's 10-year median is 18.83 vs. the industry median of 10.17, Chularat Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.17, based on 576 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chularat Hospital PCL's current Return-on-Tangible-Equity of 12.75% is 25.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Chularat Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chularat Hospital PCL's current Return-on-Tangible-Equity is 12.75%, which is 32% below median its own 10-year median of 18.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chularat Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Chularat Hospital PCL (BKK:CHG) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿2.60, compared to a current price of ฿1.51 — trading 41.9% below its estimated fair value. The current Return-on-Tangible-Equity is 12.75%, which is 32% below median its 10-year median of 18.83 and 25.4% above the Healthcare Providers & Services industry median of 10.17. Chularat Hospital PCL's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Chularat Hospital PCL (BKK:CHG), the current Return-on-Tangible-Equity is 12.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chularat Hospital PCL (BKK:CHG) Overvalued in 2026?
Based on GuruFocus' analysis, Chularat Hospital PCL stock appears to be undervalued.
The current stock price of ฿1.51 is trading 41.9% below its estimated GF Value™ of ฿2.60.
GuruFocus considers Chularat Hospital PCL to be Significantly Undervalued.
Key valuation signals for BKK:CHG:
Return-on-Tangible-Equity: 12.75% (32% below median its 10-year median of 18.83)
GF Value™: ฿2.60 vs. price of ฿1.51 (41.9% below fair value)
Industry Position: 25.4% above the Healthcare Providers & Services median (#263 of 576)
No single metric tells the full story. See the BKK:CHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chularat Hospital PCL operates hospitals and clinics in Thailand. The company operates through several branches of clinics and hospitals. The Group operates a private hospital business which is one business segment. It has only one geographical segment as the business operates only in Thailand.
81GF Score
Get the complete analysis for BKK:CHG
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:CHG has been successfully added to your 
